Assess [hlca]    
Hepatocellular carcinoma [neop]    
Risk [qlco]    
base [ftcn]    
Plus [qlco]    
treatment [ftcn]    
experience [menp]    
New [tmco]    
Highly [qlco]    
Effect [qlco]    
Oral [spco]    
antiviral drug [phsu]    
New [tmco]    
Highly [qlco]    
Effect [qlco]    
Oral [spco]    
antiviral drug [phsu]    
Hepatitis C, Chronic [dsyn]    
Virus [virs]    
indication [idcn]    
Antiviral [phsu]    
treatment [ftcn]    
Extend [cnce]    
This [euka]    
studies [mnob]    
To [qlco]    
Plus [qlco]    
treatment [ftcn]    
Evaluable [ftcn]    
Hepatocellular carcinoma [neop]    
Risk [qlco]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
Virus [virs]    
TREAT [topp]    
Not [ftcn]    
This [euka]    
Large [qnco]    
Scale [medd]    
Retrospective Studies [resa]    
Conduct [inbe]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
Virus [virs]    
Histories [ocdi]    
Hepatocellular carcinoma [neop]    
treatment [ftcn]    
Group [idcn]    
treatment [ftcn]    
Group [idcn]    
treatment [ftcn]    
Group [idcn]    
patient [podg]    
TREAT [topp]    
base [ftcn]    
Achievement [bhvr]    
sustain [ftcn]    
virologic [ftcn]    
Response [orga]    
sustain [ftcn]    
virologic [ftcn]    
Response [orga]    
sustain [ftcn]    
virologic [ftcn]    
Response [orga]    
Group [idcn]    
median [spco]    
Follow-up [fndg]    
Study Subject [grup]    
31 [inpr]    
month [tmco]    
Ranges [qnco]    
month [tmco]    
Three [qnco]    
year [tmco]    
Cumulative [qlco]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Rate [acty]    
sustain [ftcn]    
virologic [ftcn]    
Response [orga]    
1+ [qnco]    
sustain [ftcn]    
virologic [ftcn]    
Response [orga]    
subgroup [virs]    
Lower [spco]    
treatment [ftcn]    
Group [idcn]    
Study Subject [grup]    
Presence [topp]    
Cirrhosis [dsyn]    
Hazard Ratio [qnco]    
Age [orga]    
Hazard Ratio [qnco]    
sustain [ftcn]    
virologic [ftcn]    
Response [orga]    
Hazard Ratio [qnco]    
treatment [ftcn]    
Hazard Ratio [qnco]    
Found [qnco]    
To [qlco]    
Independence [idcn]    
Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
development [phsf]    
treatment [ftcn]    
Group [idcn]    
Age [orga]    
Presence [topp]    
Cirrhosis [dsyn]    
sustain [ftcn]    
virologic [ftcn]    
Response [orga]    
Predictor [idcn]    
Hepatocellular carcinoma [neop]    
development [phsf]    
treatment [ftcn]    
Group [idcn]    
Age [orga]    
Male [fndg]    
Presence [topp]    
Cirrhosis [dsyn]    
Independence [idcn]    
Predictor [idcn]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Hepatocellular carcinoma [neop]    
Risk [qlco]    
Increase [qnco]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
Virus [virs]    
Old age [fndg]    
Cirrhosis [dsyn]    
sustain [ftcn]    
virologic [ftcn]    
Response [orga]    
treatment [ftcn]    
treatment [ftcn]    
Activate [ftcn]    
Antiviral Therapy [topp]    
base [ftcn]    
Highly [qlco]    
Effect [qlco]    
Oral [spco]    
Drug [phsu]    
Need [qlco]    
To [qlco]    
consider [idcn]    
patient [podg]    
